MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers by Mehdi Sajjadi-Dokht, Talar Ahmad Merza Mohamad, Heshu Sulaiman Rahman, Marwah Suliman Maashi, Svetlana Danshina, Navid Shomali, Saeed Solali, Faroogh Marofi, Elham Zeinalzadeh, Morteza Akbari, Ali Adili, Ramin Aslaminabad, Majid Farshdousti Hagh, Mostafa Jarahian

Subjects: Get full text

Anti-myeloma Effects of Icariin Are Mediated Through the Attenuation of JAK/STAT3-Dependent Signaling Cascade by Young Yun Jung, Jong Hyun Lee, Dongwoo Nam, Acharan S. Narula, Ojas A. Namjoshi, Bruce E. Blough, Jae-Young Um, Gautam Sethi, Gautam Sethi, Gautam Sethi, Kwang Seok Ahn

Subjects: Get full text

Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics by Balakumar Chandrasekaran, Muthupandian Saravanan

Subjects: Get full text

De go Ivvár. Som om det var Iver Jåks by Irene Snarby

Subjects: “…Iver Jåks…”
Get full text

Drugs for COVID-19: An Update by Jessica Ceramella, Domenico Iacopetta, Maria Stefania Sinicropi, Inmaculada Andreu, Annaluisa Mariconda, Carmela Saturnino, Federica Giuzio, Pasquale Longo, Stefano Aquaro, Alessia Catalano

Subjects: Get full text

Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review by Nem Kumar Jain, Nem Kumar Jain, Mukul Tailang, Hemant Kumar Jain, Balakumar Chandrasekaran, Biswa Mohan Sahoo, Anandhalakshmi Subramanian, Neelaveni Thangavel, Afaf Aldahish, Kumarappan Chidambaram, M. Alagusundaram, Santosh Kumar, Palani Selvam

Subjects: Get full text

Role of Janus-Kinases in Major Depressive Disorder by Anne Gulbins, Heike Grassmé, Richard Hoehn, Marcus Kohnen, Michael J. Edwards, Johannes Kornhuber, Erich Gulbins

Subjects: “…Janus kinases (Jaks)…”
Get full text

Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3 by Li S, Xia Y, Chen K, Li J, Liu T, Wang F, Lu J, Zhou Y, Guo C

Subjects: Get full text

“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway by Emira Bousoik, Emira Bousoik, Hamidreza Montazeri Aliabadi

Subjects: “…janus tyrosine kinases (JAKs)…”
Get full text

Interaction of the intestinal cytokines-JAKs-STAT3 and 5 axes with RNA N6-methyladenosine to promote chronic inflammation-induced colorectal cancer by Nardana Esmaeili, Nardana Esmaeili, Ahmed Bakheet, Ahmed Bakheet, William Tse, Shujun Liu, Xiaonan Han, Xiaonan Han, Xiaonan Han

Subjects: “…JAKs…”
Get full text

Protective effects of Isodon Suzhouensis extract and glaucocalyxin A on chronic obstructive pulmonary disease through SOCS3–JAKs/STATs pathway by Kefeng Zhai, Wei Wang, Mengqing Zheng, Ghulam Jilany Khan, Qunbo Wang, Jingwen Chang, Zeng Dong, Xingtao Zhang, Hong Duan, Zipeng Gong, Hui Cao

Subjects: Get full text

Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis by Ronan Talty, BS, William Damsky, MD, PhD, Brett King, MD, PhD

Subjects: “…JAK…”
Get full text

Role of janus kinase inhibitors in the treatment of alopecia areata by Triyangkulsri K, Suchonwanit P

Subjects: Get full text

Treatment of Atopic Dermatitis Using JAK Inhibitors: A Systematic Review by Stefan Siedlikowski, Vijay Sandhu, Charles Lynde

Subjects: Get full text

Biological Evaluations and Computer-Aided Approaches of Janus Kinases 2 and 3 Inhibitors for Cancer Treatment: A Review by Lenci K. Vázquez-Jiménez, Gildardo Rivera, Alfredo Juárez-Saldivar, Jessica L. Ortega-Balleza, Eyra Ortiz-Pérez, Elena Jaime-Sánchez, Alma Paz-González, Edgar E. Lara-Ramírez

Subjects: Get full text

Loss of JAK1 Drives Innate Immune Deficiency by Agnieszka Witalisz-Siepracka, Klara Klein, Daniela Prinz, Nicoletta Leidenfrost, Gernot Schabbauer, Alexander Dohnal, Veronika Sexl

Subjects: “…JAK-STAT…”
Get full text

Biologic and Small Molecule Therapy in Atopic Dermatitis by Mahek Shergill, Barinder Bajwa, Orhan Yilmaz, Karishma Tailor, Naila Bouadi, Ilya Mukovozov

Subjects: Get full text

Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib by Novin Nezamololama, Keira Fieldhouse, Kristy Metzger, Melinda Gooderham

Subjects: Get full text

The Efficacy and Safety of Abrocitinib as a Treatment Option for Atopic Dermatitis: A Short Report of the Clinical Data by Napolitano M, Fabbrocini G, Ruggiero A, Marino V, Nocerino M, Patruno C

Subjects: Get full text

Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series by He X, Yang D, Lai L, Lang J, Wei K, Xiao M

Subjects: Get full text